医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New Study Shows Garlock’s GYLON BIO-PRO® Sanitary Gasket Meets Highest Industry Standards

2015年06月02日 PM11:00
このエントリーをはてなブックマークに追加


 

PALMYRA, N.Y.

The Garlock family of companies is proud to announce that a new study confirmed that the GYLON BIO-PRO® sanitary gasket meets the high standards of quality and performance required for use in pharmaceutical and bioprocessing industries.

Independently studied by the Bio-Process Institute in North Kingstown, R.I., the gasket met or exceeded all requirements of the 2014 American Society of Mechanical Engineers bioprocessing equipment standards (ASME-BPE) for intrusion and recession characteristics.

The tests focused on three main areas of performance:

  • Fit-up and dimensional conformance
  • Process exposure (up to 500 simulated Steam-In-Place cycles and 22 hydraulic flow cycles)
  • Chemical compatibility at accelerated temperature and chemical conditions

“GYLON BIO-PRO® sanitary gaskets have been used successfully in critical pharmaceutical and bioprocessing applications around the world for nearly a decade,” said Stephen Doherty, Global Pharmaceutical Segment Leader at Garlock. “We’re pleased this study by a respected, independent institution confirms that the GYLON BIO-PRO® gasket is truly a best-in-class gasket choice.”

The GYLON BIO-PRO® gasket is defined by outstanding sealing performance and dimensional stability, allowing it to meet even the most challenging chemical and temperature requirements. A GYLON® BIO-PRO demonstration video highlighting product features and benefits is now available online at http://www.garlock.com/en/products/gylon-bio-pro.

“Garlock’s long-standing expertise in PTFE [Polytetrafluoroethylene] technology and ongoing commitment to product development continues to meet the ever-increasing demands of the pharmaceutical and bioprocessing industries,” said Chris Hicks, Senior Product Manager at Garlock. “We are excited about the results and look forward to the continued success of the GYLON BIO-PRO® gasket.”

Official certificates of conformance and compliance have been issued and are now available online. (See right hand column under resources: http://www.garlock.com/en/markets/pharmaceutical/). These certificates demonstrate the gasket’s excellent dimensional characteristics and can be independently audited as part of any change control procedure.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150602005180/en/

CONTACT

Garlock Family of Companies
Mari Foley
Global Marketing
Communications Manager
315-597-3183
mari.foley@garlock.com

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)